Climb Bio, Inc. · NASDAQ:CLYM
Ra Capital Management, L.P. reported a 33.00% stake in Climb Bio, Inc. (Schedule 13D/A)
Event Dec 11, 2025 · Filed Dec 15, 2025
Ra Capital Management, L.P. reported a 33.00% stake in Climb Bio, Inc., 17,953,284 shares, with active intent on Dec 11, 2025. Filed Dec 15, 2025 (Schedule 13D/A).
- Stake
- 33.00%
- Shares
- 17,953,284
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 33.00% | 17,953,284 |
| Peter Kolchinsky | 33.00% | 17,953,284 |
| Rajeev Shah | 33.00% | 17,953,284 |
| RA Capital Healthcare Fund, L.P. | 23.00% | 12,485,646 |
| RA Capital Nexus Fund III, L.P. | 11.20% | 5,346,247 |
| Sera Medicines, LLC | 5.20% | 2,479,872 |
Source
Related
- Climb Bio, Inc.
- Ra Capital Management, L.P.
- Climb Bio, Inc. shareholders
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 7, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Apr 29, 2026
- Form 4 · RA Capital Nexus Fund, L.P. · Sep 30, 2026
- Form 4 · Thomas Stephen Basil · Sep 17, 2026
- Schedule 13G/A · Mpm Bioimpact LLC · Aug 14, 2026
- Schedule 13G · FMR LLC · Jul 8, 2026
- Form 4 · Brennan Aoife · Jun 30, 2026